Studies have shown that dietary flavonoids, including those found in green tea, should be avoided in patients taking bortezomib as a chemotherapeutic drug. Bortezomib inhibits proteasome and is used for treatment in patients with relapsed and refractory multiple myeloma.
Green tea extract has shown potential heart protection in patients taking doxorubicin. Patients with rheumatoid arthritis taking infliximab who also consumed green tea have shown additional clinical improvement. No consensus has been reached about green tea and gabapentin.
Learn more about indications and considerations regarding green tea.
Medscape © 2022 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Elwyn C. Cabebe. Fast Five Quiz: Tea and Health - Medscape - Aug 03, 2022.